Download Docs
Export

AKTIV PHARMA GROUP

97512070 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed July 20, 2022
Serial No. 97512070
Examining Attorney DAVIS CREEF
Interlocutory Attorney MARY CATHERINE FAINT
Class Nausea treatment preparations; Pharmaceutical preparations for the treatment of organophosphate poisoning; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; 005; 006; 018; 044; 046; 051; 052; 026; 039; 044; 002; 013; 022; 025; 032; 050; 002; 013; 023; 029; 030; 033; 040; 050; 100; 103; 106
AKTIV PHARMA GROUP
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Opposition 91288586
Actavis Holdco US, Inc. v. AktiVax, Inc.
  • AktiVax, Inc.;
  • Actavis Holdco US, Inc.;
Opposition 97512070
Actavis Holdco US, Inc. v. AktiVax, Inc.
  • AktiVax, Inc.;
  • Actavis Holdco US, Inc.;
Last Updated: 2 months, 2 weeks ago
Filing Date # Docket Text